Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial

Abstract Background Most previous studies used aluminum hydroxide-absorbed allergen extracts in evaluating the potential therapeutic roles of intralymphatic allergen-specific immunotherapy (ILAIT). In this study, we evaluated the therapeutic efficacy and safety of ILAIT with L-tyrosine-adsorbed alle...

Full description

Bibliographic Details
Main Authors: Hye Jung Park, Sae-Hoon Kim, Yoo Seob Shin, Chul Hwan Park, Eun-Suk Cho, Seung Joon Choi, So Hyun Park, Joo Hyun Jung, Il Gyu Kang, Myoung Seok Lee, Dae Woo Kim, Sang Min Lee, Min-Suk Yang, Sang Pyo Lee
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Respiratory Research
Subjects:
Allergic rhinitis
Allergen immunotherapy
Intralymphatic injection
Treatment efficacy
Adverse events
Online Access:https://doi.org/10.1186/s12931-021-01766-0

Internet

https://doi.org/10.1186/s12931-021-01766-0

Similar Items